Literature DB >> 4606362

Combined trivalent and bivalent measles, mumps and rubella virus vaccination. A controlled trial.

T A Swartz, W Klingberg, M A Klingberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4606362     DOI: 10.1007/bf01642228

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  14 in total

1.  Live, attenuated mumps-virus vaccine.

Authors:  M R Hilleman; E B Buynak; R E Weibel; J Stokes
Journal:  N Engl J Med       Date:  1968-02-01       Impact factor: 91.245

2.  Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies.

Authors:  J Stokes; R E Weibel; V M Villarejos; J A Arguedas; E B Buynak; M R Hilleman
Journal:  JAMA       Date:  1971-10-04       Impact factor: 56.272

3.  Clinical manifestations, according to age, among females given HPV-77 duck rubella vaccine.

Authors:  T A Swartz; W Klingberg; R A Goldwasser; M A Klingberg; N Goldblum; M R Hilleman
Journal:  Am J Epidemiol       Date:  1971-09       Impact factor: 4.897

4.  Combined live measles, mumps, rubella vaccine. Immunological response.

Authors:  S Krugman; G Muriel; V J Fontana
Journal:  Am J Dis Child       Date:  1971-05

5.  Combined live rubella-mumps virus vaccine. Findings in clinical-laboratory studies.

Authors:  R E Weibel; J Stokes; V M Villarejos; J A Arguedas; E B Buynak; M R Hilleman
Journal:  JAMA       Date:  1971-05-10       Impact factor: 56.272

6.  A comparative study of four live measles vaccines in Israel.

Authors:  T Swartz; W Klingberg; M Nishmi; N Goldblum; C Gerichter; Y Yofe; W C Cockburn
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

7.  Combined live measles, mumps, and rubella virus vaccines.

Authors:  E B Buynak; R E Weibel; J E Whitman; J Stokes; M R Hilleman
Journal:  JAMA       Date:  1969-03-24       Impact factor: 56.272

8.  Live attenuated rubella virus vaccines. Experiences with duck embryo cell preparations.

Authors:  M R Hilleman; E B Buynak; J E Whitman; R W Weibel; J Stokes
Journal:  Am J Dis Child       Date:  1969-08

9.  Live attenuated mumps virus vaccine. II. Early clinical studies.

Authors:  J Stokes; R E Weibel; E B Buynak; M R Hilleman
Journal:  Pediatrics       Date:  1967-03       Impact factor: 7.124

10.  Experience with live rubella virus vaccine combined with live vaccines against measles and mumps.

Authors:  A A Smorodintsev; M N Nasibov; N V Jakovleva
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

View more
  4 in total

Review 1.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 2.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

3.  Knowledge synthesis of benefits and adverse effects of measles vaccination: the Lasbela balance sheet.

Authors:  Robert J Ledogar; John Fleming; Neil Andersson
Journal:  BMC Int Health Hum Rights       Date:  2009-10-14

4.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.